Fracture Healing in a Late-Onset Alzheimer’s Disease (LOAD2) Mouse Model

Authors

  • Nihal Nagesh Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center https://orcid.org/0009-0005-0498-6844
  • Amy Creecy Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center
  • Sonali Karnik Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center
  • Rachel Blosser Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center
  • Kuldeep Yadav Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center
  • Sarah Mostardo Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center
  • Timothy Meyer Behavioral Phenotyping Core, Indiana University School of Medicine
  • Kathyrn Fischer Behavioral Phenotyping Core, Indiana University School of Medicine
  • Adrian Oblak Stark Neurosciences Research Institute, Indiana University School of Medicine
  • Melissa Kacena Department of Orthopaedic Surgery, Indiana University School of Medicine; Richard L. Roudebush VA Medical Center

DOI:

https://doi.org/10.18060/29662

Abstract

Osteoporotic fractures are a major cause of morbidity in the aging population. Alzheimer’s Disease (AD) has been shown to increase fracture risk by ~2-fold (1). Mechanistic studies show that AD-associated neuroinflammation and the late-onset AD (LOAD2) risk alleles APOE4 and TREM2 R34H promote RANKL-mediated osteoclastogenesis, which, along with reduced activity, may lower bone mineral density (2, 3). We also remain uncertain whether fracture itself or the anesthesia required for surgery might modify the trajectory of AD pathology in mice. We hypothesized that APOE4/TREM2-driven neuroinflammation in LOAD2 mice impairs fracture healing.

To test this, we used a LOAD2 mouse model carrying humanized APOE4 and TREM2 R34H, which recapitulates AD-like neuroinflammation without extensive amyloid or tau deposition (4). Mice were assigned to four groups: C57BL/6J unfractured, C57BL/6J fractured, LOAD2 unfractured, and LOAD2 fractured. C57BL/6J is henceforth referred to as B6. Femoral fractures were created and stabilized using a surgical osteotomy technique at 1 year of age. Animals that were not in the fracture group were shaved, given Ethica, and received equal isoflurane exposure. Grip strength, Y-maze (distance and % spontaneous alternation), and light/dark testing were performed at baseline, 10 weeks, and 20 weeks post-fracture. Healing was monitored by serial X-rays (biweekly from day 7 to week 5, then weekly from weeks 6-12, and every other week thereafter until sacrifice) and quantified at 40 weeks post-fracture using micro-computed tomography (μCT).

Male LOAD2 control femurs showed a smaller cross-sectional area (B.Ar) and a lower bonevolume-fraction (BV/TV) relative to B6. At 40 weeks post-fracture, female LOAD2 fractured femurs displayed a higher BV/TV with unchanged B.Ar. Female LOAD2 control femurs showed greater cortical thickness. Behaviorally, 20-wk post-fracture testing demonstrated no genotype-specific deficits; the only significant difference was a modest reduction in Y-maze distance in fractured B6 males compared to B6 control males. Spontaneous alternation, darkphase locomotor time, and grip strength were unaffected across groups. These findings suggest that LOAD2 produces subtle sex-specific increases in cortical bone density without compromising functional recovery after femoral fracture in mice.

Downloads

Published

2026-03-30

Issue

Section

Abstracts